Article
[Advances of Targeting Therapy in Acute Myeloid Leukemia--Review].
Zhongguo shi yan xue ye xue za zhi - 1 Aug 2018
Tian Chen, Li Yue-Yang, Hu Dong-Zhi
Abstract excerpt
Although the application of combined chemotherapy has made a great progress in treatment of adult acute myeloid leukemia (AML), the overall survival rate is still not high, mainly because of high recurrence rate and drug resistance. The treatment regimen for relapsed/refractory AML is always strong. Due to the chemotherapy drugs lacking of specific identification of tumor cells, significant adverse reactions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
